Anti Doping Case Study

ISSUES AND CHALLENGES

KAVYAASRINI A/P S.MAHENDRAN (A153519)

3.1 SCIENTIFIC LIMITATIONS (LABORATORY TESTS, TECHNOLOGY)

There are some issues and challenges that may be faced in balancing the justices in anti-doping regulation by the government agencies. Human are human, they tend to make mistakes and every matter that the human created has its limitation. For example, in daily life, a car can only be on road and if it is drove in the water it will encounter damages. The same goes to the doping scenario. Anti–doping jurisprudence in most legal systems in the world still remains far from perfect as stated by Jady Zaidi Hassim in his book Sports Law in Malaysia.

One of the most difficult issues are faced by scientists who research performance

MAR and Boulaimi, CAS 2003/A/383, Award of 19 November 2003,the panel found that the World Anti Doping Agency (WADA) criteria for establishing a positive test had a "reasonable cut-off point that largely eliminates the risk of false positives in urinary rEPO tests".But in August 2005, a Flemish government disciplinary commission overturned the suspension of Belgian triathlete Rutger Beke after he was able to show that strict application of the latest WADA criteria could result in a positive finding, even in cases where a true positive could not be scientifically verified. The following month, two Spanish triathletes were cleared of EPO use charges because of similar doubts about their positive tests. Some laboratories more experienced with EPO testing use a stricter set of criteria that conform to WADA standards but eliminate the possibility of prematurely reporting a positive result such as that which occurred in the Beke

One of the designer steroids at the scandal is tetrahydrogestrinone (THG).The discovery of THG was made possible through a small stroke of luck. A U.S. track coach gave a nearly empty syringe of THG to a U.S Anti-Doping Agency (USADA) official claiming that several top athletes were using the substance inside of the syringe.USADA passed the syringe along to the scientists at the University of California, Los Angeles (UCLA) Olympic Analytical Laboratory who synthesized the drug themselves and developed a method to detect its presence in